Hemostatic disorder of uremia: The platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis
Loading...
Date
1996
Journal Title
Journal ISSN
Volume Title
Publisher
GEORG THIEME VERLAG KG
Abstract
Several parameters of primary hemostasis and markers of activation of coagulation and fibrinolysis were measured in 38 patients with severe (creatinine clearance <20 ml/min) chronic renal failure (CRF) without dialysis and diseases or drugs affecting hemostasis. Bleeding time (BT) was prolonged in 25/48 patients, and was correlated with age of patients, severity of renal failure, hematocrit, impairment in platelet aggregation-secretion and decrease in platelet ATP content. Defects in von Willebrand factor played no role in the prolongation of the BT. Multivariate analysis showed that only platelet dysfunction and severity of renal disease were independent predictors of the BT in uremia. The platelet functional disorder was significantly correlated with a reduction in platelet ATP and ADP.
High levels of plasma thrombin-antithrombin complexes (TAT), prothrombin fragment F-1+2, fibrinogen and factor VIIc were observed in patients with CRF, as described in prethrombotic states. Plasmin-antiplasmin complexes (PAP), fibrinogen and fibrin degradation products (FgDP, FnDP) were significantly increased, and the activity of plasminogen activator Inhibitor (PAI-I) was slightly reduced, denoting an activation of fibrinolysis.
A negative correlation was found between platelet levels of ATP and ADP with plasma TAT, F-1+2 and PAP. Furthermore, plasma PAI-1 activity was negatively correlated with the BT and was lower in patients with prolonged BT as compared with controls and patients with normal BT. These links between primary hemostasis and activation of coagulation and fibrinolysis suggest that increased intravascular generation of thrombin and/or plasmin is an important mediator of the defects in primary hemostasis, prolongation of the BT and, probably, bleeding in CRF.
High levels of plasma thrombin-antithrombin complexes (TAT), prothrombin fragment F-1+2, fibrinogen and factor VIIc were observed in patients with CRF, as described in prethrombotic states. Plasmin-antiplasmin complexes (PAP), fibrinogen and fibrin degradation products (FgDP, FnDP) were significantly increased, and the activity of plasminogen activator Inhibitor (PAI-I) was slightly reduced, denoting an activation of fibrinolysis.
A negative correlation was found between platelet levels of ATP and ADP with plasma TAT, F-1+2 and PAP. Furthermore, plasma PAI-1 activity was negatively correlated with the BT and was lower in patients with prolonged BT as compared with controls and patients with normal BT. These links between primary hemostasis and activation of coagulation and fibrinolysis suggest that increased intravascular generation of thrombin and/or plasmin is an important mediator of the defects in primary hemostasis, prolongation of the BT and, probably, bleeding in CRF.
Description
Keywords
CHRONIC-RENAL-FAILURE, GLYCOPROTEIN-IIB-IIIA, RED-CELL TRANSFUSIONS, VONWILLEBRAND-FACTOR, ENDOTHELIAL-CELLS, PLASMINOGEN-ACTIVATOR, ANTITHROMBIN-III, MAINTENANCE HEMODIALYSIS, ADENOSINE-DIPHOSPHATE, FIBRINOGEN RECEPTORS